Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02730338 · ClinicalTrials.gov registry record · NA

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

A NA study of Metastatic Prostate Cancer, sponsored by Movember Foundation.

Active
Registry status
NA
Development phase
866
Enrollment target
18
Study locations

NCT02730338 is a NA study of Metastatic Prostate Cancer that is active but no longer recruiting, run by Movember Foundation. The registered enrollment target is 866 participants, above the 165-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (425% higher). The trial reports 18 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02730338, a NA study of Metastatic Prostate Cancer, is active but no longer recruiting, sponsored by Movember Foundation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
866 participants
Enrollment target
18
Study locations

Study Summary

To determine if supervised high intensity aerobic and resistance training increases overall survival compared to self-directed exercise in patients with metastatic prostate cancer.

Conditions Studied

Interventions

  • BEHAVIORAL High intensity aerobic and resistance training
  • BEHAVIORAL Psychosocial support

Study Locations (18)

Other

  • Centre Hospitalier de l'Université de Montréal (CRCHUM) - Montreal
  • German Sport University Cologne - Cologne
  • Erasmus MC - Rotterdam
  • Queen's University Belfast - Belfast
  • University of Glasgow - Glasgow
  • Kings College London - London

California

  • Cedars Sinai Medical Centre - Los Angeles
  • UCSF - San Francisco

Queensland

  • Australian Prostate Cncr Research Centre - Brisbane
  • University of Queensland - Brisbane

Colorado

  • UC Denver - Denver

Minnesota

  • University of Minnesota - Minneapolis

Oregon

  • Oregon Health & Science University - Portland

Washington

  • Fred Hutchinson Cancer Centre - Seattle

Victoria

  • Victoria University / Sunshine Hospital - Melbourne

Trial Details

FieldValue
Enrollment Target 866 participants
Start Date 2016-01
Est. Completion 2026-10
Phase NA

Sponsor

Movember Foundation

1 total trials

What the Registry Record Tells You About NCT02730338

The ClinicalTrials.gov registry entry for NCT02730338 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 866 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 165-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (425% higher). The listed sponsor is Movember Foundation, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metastatic Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which High intensity aerobic and resistance training is the first listed.

NCT02730338 reports 18 study locations spanning 11 distinct geographic areas - top geographies include Other, California, Queensland.

Frequently Asked Questions

What is clinical trial NCT02730338 about?

NCT02730338 is a clinical study titled "INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)". To determine if supervised high intensity aerobic and resistance training increases overall survival compared to self-directed exercise in patients with metastatic prostate cancer.

What is the current status of trial NCT02730338?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 866 participants. The study started on 2016-01. Estimated completion is 2026-10.

What conditions does trial NCT02730338 study?

This clinical trial studies the following conditions: Metastatic Prostate Cancer.

What interventions are being tested in trial NCT02730338?

The interventions under investigation include: High intensity aerobic and resistance training (BEHAVIORAL), Psychosocial support (BEHAVIORAL).

Who is sponsoring clinical trial NCT02730338?

This trial is sponsored by Movember Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02730338 being conducted?

This trial has 18 study locations across California, Colorado, Minnesota, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metastatic Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.